| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Methodist Health System, 3 hospitals, 21 clinic locations, a nursing and allied health college, in Omaha, NE
Memorial Hospital is a proud part of University of Colorado Health, recognized as a national leader in quality and research. At the local level, Memorial provides a comprehensive list of inpatient and outpatient services at two hospitals and multiple outpatient locations. Memorial provides state-of-the-art, compassionate care in fields such as cardiology, neurology and oncology.
Founded in 1908, Hu-Friedy has since become a world leader in dental instrument manufacturing. Today, we take a broader view of the value we offer our customers. We are focused on delivering the highest quality product, service, and community experience in the dental industry in order to help dental professionals perform at their best. Our 10,000 dental instruments and product solutions are sold in over 100 countries, and we have more than 600 employees representing and growing our brand around the world. Headquartered in Chicago, we have offices and distribution centers in the Netherlands, Italy, Germany, China, and Japan, and a sales force spread over 30 different countries.
Travel Nurses, Inc. is a healthcare staffing agency that provides travel nurse contracts and staffing services for nurses and allied professionals nationwide.